Theriva Biologics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2022
Total Assets: $71.9M
Liabilities Breakdown FY2022
Total Liabilities: $17.3M
Asset Breakdown
Total Assets: $71.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $41.8M | 58.1% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $345.0K | 0.5% |
| Goodwill | $5.5M | 7.7% |
| Intangible Assets | $19.2M | 26.6% |
| Other Assets | $5.1M | 7.0% |
Liabilities Breakdown
Total Liabilities: $17.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $915.0K | 5.3% |
| Long-Term Debt | $221.0K | 1.3% |
| Other Liabilities | $16.2M | 93.4% |